BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hyytiäinen A, Wahbi W, Väyrynen O, Saarilahti K, Karihtala P, Salo T, Al-Samadi A. Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope? Front Oncol 2021;11:683570. [PMID: 34195084 DOI: 10.3389/fonc.2021.683570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Lin C, Liu Z, Sun Y, Chen M, Guo Y, Liu W, Zhang C, Chen W, Sun J, Xia R, Hu Y, Yang X, Li J, Zhang Z, Cao W, Sun S, Wang X, Ji T. Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies. Cell Metab 2022;34:1999-2017.e10. [PMID: 36395769 DOI: 10.1016/j.cmet.2022.10.012] [Reference Citation Analysis]
2 Ludwig N, Yerneni SS, Azambuja JH, Pietrowska M, Widłak P, Hinck CS, Głuszko A, Szczepański MJ, Kärmer T, Kallinger I, Schulz D, Bauer RJ, Spanier G, Spoerl S, Meier JK, Ettl T, Razzo BM, Reichert TE, Hinck AP, Whiteside TL. TGFβ(+) small extracellular vesicles from head and neck squamous cell carcinoma cells reprogram macrophages towards a pro-angiogenic phenotype. J Extracell Vesicles 2022;11:e12294. [PMID: 36537293 DOI: 10.1002/jev2.12294] [Reference Citation Analysis]
3 Holik HA, Aristawidya L. RECENT DEVELOPMENT OF RADIONUCLIDE-BASED IMAGING IN DIAGNOSIS AND THERAPY OF LUNG CANCER: A REVIEW. Int J App Pharm 2022. [DOI: 10.22159/ijap.2022.v14s4.pp05] [Reference Citation Analysis]
4 Sun Z, Xia B, Zhang M, Xu S, Ma Y, Zhang X. Case report: Prompt response to radiotherapy and chemotherapy combined with crizotinib in gingival sarcomatoid squamous cell carcinoma with MET 14 mutation. Front Oncol 2022;12:1006516. [DOI: 10.3389/fonc.2022.1006516] [Reference Citation Analysis]
5 Rashidi M, Mahmoudian E, Mirzaei S, Mazloomi SN, Bazi A, Azadeh H, Mozaffari M. Harmaline downregulates angiogenesis markers and suppresses the growth of 4T1 breast cancer cells in vivo and in vitro. Chem Biol Interact 2022;365:110087. [PMID: 35963316 DOI: 10.1016/j.cbi.2022.110087] [Reference Citation Analysis]
6 Ghosh S, Shah PA, Johnson FM. Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2022;23:7889. [PMID: 35887235 DOI: 10.3390/ijms23147889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liu B, Liu R, Liu Q, Ashby CR Jr, Zhang H, Chen ZS. The ethnomedicinal and functional uses, phytochemical and pharmacology of compounds from Ardisia species: An updated review. Med Res Rev 2022. [PMID: 35670013 DOI: 10.1002/med.21894] [Reference Citation Analysis]
8 Salem A, Hadler-Olsen E, Al-Samadi A. Editorial: Angiogenesis and Angiogenesis Inhibitors in Oral Cancer. Front Oral Health 2021;2:816963. [PMID: 35048080 DOI: 10.3389/froh.2021.816963] [Reference Citation Analysis]
9 Fraga CAC, Souza DPSP, Lima HCS, Farias LC, Guimarães ALS. Anti-hypoxic Agents for Improving Head and Neck Cancer Therapy. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_69] [Reference Citation Analysis]